PRICE T ROWE ASSOCIATES INC /MD/ - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 169 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$261
+33.2%
45,707
+17.3%
0.00%
Q1 2024$196
-35.7%
38,952
+15.0%
0.00%
Q4 2023$305
+28.7%
33,873
+11.5%
0.00%
Q3 2023$237
-10.9%
30,379
+10.8%
0.00%
Q2 2023$266
-6.7%
27,411
+5.7%
0.00%
Q1 2023$285
+187.9%
25,927
+12.6%
0.00%
Q4 2022$99
-99.9%
23,021
+7.3%
0.00%
Q3 2022$162,000
+25.6%
21,458
+67.7%
0.00%
Q2 2022$129,000
-97.7%
12,799
-98.3%
0.00%
-100.0%
Q1 2017$5,515,000751,3000.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q2 2024
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 188,500$4,311,0003.12%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 334,500$7,647,0001.70%
IRONWOOD INVESTMENT MANAGEMENT LLC 131,760$3,013,0001.49%
NEA Management Company, LLC 3,069,834$70,207,0001.42%
Berry Street Capital Management LLP 575,000$13,151,0001.36%
Melqart Asset Management (UK) Ltd 916,321$20,956,0001.06%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$2,287,0000.93%
HighMark Wealth Management LLC 50,499$1,155,0000.73%
Artal Group S.A. 1,000,000$22,870,0000.62%
Vigilare Wealth Management 34,925$799,0000.47%
View complete list of AURINIA PHARMACEUTICALS INC shareholders